Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-06-13 Sale |
2024-06-17 6:42 pm |
uniQure N.V. | QURE | Jacques Rachelle Suzanne Director |
2,221 | $5.14 | $11,416 | 14,408 (Direct) |
View |
2023-06-16 Sale |
2023-06-20 5:33 pm |
uniQure N.V. | QURE | Jacques Rachelle Suzanne Director |
2,301 | $18.76 | $43,167 | 33,689 (Direct) |
View |
2023-02-27 Sale |
2023-03-01 4:11 pm |
uniQure N.V. | QURE | Jacques Rachelle Suzanne Director |
384 | $20.02 | $7,688 | 10,230 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-06-19 Option Award |
2024-06-21 4:57 pm |
N/A 2034-06-19 |
uniQure N.V. | QURE | Jacques Rachelle Suzanne Director |
23,920 | $0 | 38,328 (Direct) |
View |
2024-05-30 Option Award |
2024-06-03 4:29 pm |
N/A N/A |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Jacques Rachelle Suzanne Director |
2,783 | $0 | 2,783 (Direct) |
View |
2024-05-16 Option Award |
2024-05-20 4:58 pm |
N/A 2034-05-16 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Jacques Rachelle Suzanne Director |
2,783 | $0 | 2,783 (Direct) |
View |
2024-04-26 Option Award |
2024-04-30 9:45 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Jacques Rachelle Suzanne Chief Executive Officer |
479,569,892 | $0 | 1,018,027,792 (Direct) |
View |
Ownership |
2024-01-02 8:06 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Jacques Rachelle Suzanne Chief Executive Officer |
0 | $0 | 928,545,300 (Direct) |
View |
2023-06-13 Option Award |
2023-06-20 5:33 pm |
N/A 2033-06-13 |
uniQure N.V. | QURE | Jacques Rachelle Suzanne Director |
25,760 | $0 | 33,689 (Direct) |
View |
2023-05-18 Option Award |
2023-05-22 4:27 pm |
N/A 2033-05-18 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Jacques Rachelle Suzanne Director |
5,300 | $0 | 5,300 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 5:03 pm |
N/A 2032-06-15 |
uniQure N.V. | QURE | Jacques Rachelle Suzanne Director |
26,890 | $0 | 28,424 (Direct) |
View |
2022-05-18 Option Award |
2022-05-19 2:41 pm |
N/A 2032-05-18 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Jacques Rachelle Suzanne Director |
79,600 | $0 | 79,600 (Direct) |
View |
2022-02-24 Option Award |
2022-02-28 6:10 pm |
N/A 2032-02-24 |
uniQure N.V. | QURE | Jacques Rachelle Suzanne Director |
4,179 | $0 | 4,179 (Direct) |
View |
2021-10-21 Option Award |
2021-10-22 8:09 pm |
N/A 2031-10-21 |
uniQure N.V. | QURE | Jacques Rachelle Suzanne Director |
10,000 | $0 | 10,000 (Direct) |
View |
2021-06-17 Option Award |
2021-06-17 4:42 pm |
N/A 2031-06-17 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Jacques Rachelle Suzanne Director |
116,400 | $0 | 116,400 (Direct) |
View |
2020-06-19 Option Award(A) |
2020-06-24 4:47 pm |
N/A 2030-06-18 |
Viela Bio Inc. | VIE | Jacques Rachelle Suzanne Director |
22,074 | $0 | 22,074 (Direct) |
View |
2020-06-19 Option Award |
2020-06-23 4:41 pm |
N/A 2030-06-19 |
Viela Bio Inc. | VIE | Jacques Rachelle Suzanne Director |
14,716 | $0 | 14,716 (Direct) |
View |
2020-05-20 Option Award |
2020-05-22 3:00 pm |
N/A 2030-05-20 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Jacques Rachelle Suzanne Director |
40,500 | $0 | 40,500 (Direct) |
View |